Loading...
Market
How will the $300 million opioid settlement impact the stock prices of the three largest U.S. drug distributors by the end of 2024?
2
Resolution / Starting Odds
All three increase • 25%
All three decrease • 25%
Mixed results • 25%
No significant change • 25%
Stock market data from financial websites
Story
U.S. Drug Distributors to Pay $300 Million in Opioid Settlement
Aug 30, 2024, 09:52 PM
The three largest U.S. drug distributors have agreed to pay $300 million to resolve claims by health insurers and benefit plans that they contributed to the U.S. opioid epidemic. This settlement, as reported in court papers filed on Friday, addresses allegations that these distributors played a role in the widespread opioid crisis by failing to monitor and report suspicious orders of prescription painkillers.
View original story
Similar markets
Significant decline in business operations • 25%
Minor impact on business operations • 25%
No impact on business operations • 25%
Improvement in business operations • 25%
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
Johnson & Johnson • 25%
Teva Pharmaceuticals • 25%
Endo International • 25%
Other • 25%
Yes • 50%
No • 50%
Increase • 25%
Decrease • 25%
No significant change • 25%
Uncertain/Other • 25%
Significant increase • 25%
Significant decrease • 25%
No significant change • 25%
Volatile changes • 25%
Yes • 50%
No • 50%
Less than $1 billion • 25%
$1 billion to $1.5 billion • 25%
$1.5 billion to $2 billion • 25%
More than $2 billion • 25%
